NCT04285957

Brief Summary

This study is aimed at providing an Italian version of two assessment tools for participation in stroke patients, the Frenchay Activity Index (FAI) and the Walking Handicap Classification (WHC) by a standardized translation and transcultural validation protocol. The protocol includes a pre-test of the Italian version on ten patients, a final revision, and a validation on a sample of 60 stroke patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 25, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 26, 2020

Completed
7 months until next milestone

Study Start

First participant enrolled

September 15, 2020

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 14, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2021

Completed
Last Updated

March 17, 2025

Status Verified

March 1, 2025

Enrollment Period

12 months

First QC Date

February 25, 2020

Last Update Submit

March 13, 2025

Conditions

Keywords

participationFrenchay Activity IndexWalking Handicap ClassificationStroke Rehabilitation

Outcome Measures

Primary Outcomes (4)

  • Interrater reliability

    Intraclass Correlation Coefficient \>=0,70

    1 year

  • Internal consistency (FAI)

    Cronbach's alpha\>=0,70

    1 year

  • concurrent validity of FAI against SIP

    Spearman's coefficient \>=0.25-0.50

    1 year

  • concurrent validity of WHC against RMI

    Spearman's coefficient \>=0.25-0.50

    1 year

Study Arms (2)

pre-test Group

Consecutive recruitment of 10 post-stroke patients undergoing intensive rehabilitation treatment at the Neurological Rehabilitation Unit, Foundation don Gnocchi Scientific Institute. Inclusion criteria: age 18-90, stroke occurred within 3 months from enrollment; clinical stability (SIC = 0). The exclusion criteria are: stroke recurrence; visual and / or hearing disorders; cognitive decline (MMSE \<21) and/or severe aphasia, which would limit the the patients' understanding of and the reliable answering to the two assessment tools

Other: Questionnaire administration pre test

Validation Group

Recruitment of 60 post-stroke patients undergoing intensive rehabilitation treatment at the Neurological Rehabilitation Unit, Foundation don Gnocchi Scientific Institute.Inclusion criteria: age 18-90, stroke occurred within 8 months from enrollment; clinical stability (SIC = 0). If the following criteria are present: visual and / or hearing disorders; cognitive decline (MMSE \<21) and/or severe aphasia, which would limit the patients' understanding of and the reliable answering to the two assessment tools, the interview shall be carried out with a proxy

Other: Questionnaire administration - validation

Interventions

Pre-test: Two expert physicians/physical therapist shall be involved in the questionnaire administration (A/B). The questionnaires shall be randomly administered to the patients by one operator at T0 the same test shall be readministered after 1-2 weeks by another operator (T1), blind to the first assessment; the second operator shall also administer the additional measures (SIP and RMI);

Also known as: Questionnaire administration - validation
pre-test Group

Validation Two expert physicians shall be involved in the questionnaire administration (A/B). The questionnaires shall be randomly administered to the patients by one operator at T0 the same test shall be readministered after 1-2 weeks by another operator (T1), blind to the first assessment; the second operator shall also administer the additional measures (SIP and RMI); In case the patient is unable to be interviewed due to aphasia cognitive or sensorial problems, a proxy would be interviewed both at T0 and at T1 (the same proxy would be interviewed both times)

Validation Group

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Pre-test: 10 consecutively recruited post-stroke patients undergoing intensive rehabilitation treatment at the Neurological Rehabilitation Unit, Foundation don Gnocchi Scientific Institute.Inclusion and exclusion criteria listed in the dedicated section. Validation: 60 post-stroke patients undergoing intensive rehabilitation treatment at the Neurological Rehabilitation Unit, Foundation don Gnocchi Scientific Institue.Inclusion and exclusion criteria listed in the dedicated section. If the following are present: visual and / or hearing disorders; cognitive decline (MMSE \<21) and/or severe aphasia, which would limit the patients' understanding of and the reliable answering to the two assessment tools, the interview shall be carried out with a proxy

You may qualify if:

  • age 18-90;
  • stroke occurred within 3 months from enrollment;
  • clinical stability (SIC = 0).

You may not qualify if:

  • stroke recurrence;
  • visual and / or hearing disorders;
  • cognitive decline (MMSE \<21) and/or severe aphasia, which would limit the the patients' understanding of and the reliable answering to the two assessment tools
  • Validation: recruitment of 60 post-stroke patients undergoing intensive rehabilitation treatment at the Neurological Rehabilitation Unit, Foundation don Gnocchi Scientific Institute-
  • age 18-90,
  • stroke occurred within 8 months from enrollment;
  • clinical stability (SIC = 0).
  • Criteria for carrying out the interview with a proxy. If a proxy is not available, the patient is excluded:
  • visual and / or hearing disorders;
  • cognitive decline (MMSE \<21) and/or severe aphasia, which would limit the patients' understanding of and the reliable answering to the two assessment tools.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione don Gnocchi

Florence, 50143, Italy

Location

Study Officials

  • Francesca Cecchi, Md

    Fondazione don Carlo Gnocchi IRCCS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 25, 2020

First Posted

February 26, 2020

Study Start

September 15, 2020

Primary Completion

September 14, 2021

Study Completion

November 15, 2021

Last Updated

March 17, 2025

Record last verified: 2025-03

Locations